Translational Predictive Biomarker Analysis of the Phase 1b Sorafenib and Bevacizumab Study Expansion Cohort
出版年份 2013 全文链接
标题
Translational Predictive Biomarker Analysis of the Phase 1b Sorafenib and Bevacizumab Study Expansion Cohort
作者
关键词
-
出版物
MOLECULAR & CELLULAR PROTEOMICS
Volume 12, Issue 6, Pages 1621-1631
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2013-03-02
DOI
10.1074/mcp.m112.026427
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Assessing the in vivo efficacy of biologic antiangiogenic therapies
- (2012) Peter M. Wilson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Association between VEGF Splice Isoforms and Progression-Free Survival in Metastatic Colorectal Cancer Patients Treated with Bevacizumab
- (2012) D. O. Bates et al. CLINICAL CANCER RESEARCH
- Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia
- (2012) C. J. Peer et al. CLINICAL CANCER RESEARCH
- Predictive Impact of Circulating Vascular Endothelial Growth Factor in Four Phase III Trials Evaluating Bevacizumab
- (2012) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials
- (2012) Diether Lambrechts et al. LANCET ONCOLOGY
- A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma
- (2011) A. J. Zurita et al. ANNALS OF ONCOLOGY
- FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer
- (2011) F Bertolini et al. BRITISH JOURNAL OF CANCER
- Population pharmacokinetic analysis of sorafenib in patients with solid tumours
- (2011) Lokesh Jain et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome
- (2011) Geoffrey Kim et al. CANCER
- Sorafenib as a third line therapy in patients with epithelial ovarian cancer or primary peritoneal cancer: A phase II study
- (2011) Lubomir Bodnar et al. GYNECOLOGIC ONCOLOGY
- Tumor Metabolism and Perfusion in Head and Neck Squamous Cell Carcinoma: Pretreatment Multimodality Imaging With 1H Magnetic Resonance Spectroscopy, Dynamic Contrast-Enhanced MRI, and [18F]FDG-PET
- (2011) Jacobus F.A. Jansen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Proteomics and biomarkers in clinical trials for drug development
- (2011) Jung-min Lee et al. Journal of Proteomics
- Chemotherapy and targeted therapies for unresectable malignant mesothelioma
- (2011) Ronan Joseph Kelly et al. LUNG CANCER
- Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity
- (2010) J-M Lee et al. BRITISH JOURNAL OF CANCER
- Biomarker-Driven Early Clinical Trials in Oncology
- (2010) Daniel S. W. Tan et al. CANCER JOURNAL
- Vandetanib, Designed to Inhibit VEGFR2 and EGFR Signaling, Had No Clinical Activity as Monotherapy for Recurrent Ovarian Cancer and No Detectable Modulation of VEGFR2
- (2010) C. M. Annunziata et al. CLINICAL CANCER RESEARCH
- Antiangiogenic and antitumor activity of LP-261, a novel oral tubulin binding agent, alone and in combination with bevacizumab
- (2010) Erin R. Gardner et al. INVESTIGATIONAL NEW DRUGS
- Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial
- (2010) Daniela Matei et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib
- (2010) Lokesh Jain et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Imaging of Tumor Angiogenesis: Functional or Targeted?
- (2009) Baris Turkbey et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Anticancer strategies involving the vasculature
- (2009) Victoria L. Heath et al. Nature Reviews Clinical Oncology
- Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity
- (2008) Nilofer S. Azad et al. JOURNAL OF CLINICAL ONCOLOGY
- The Lessons of GIST--PET and PET/CT: A New Paradigm for Imaging
- (2008) A. D. Van den Abbeele ONCOLOGIST
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started